Delta-9-tetrahydrocannabinol protects cardiac cells from hypoxia via CB2 receptor activation and nitric oxide production
Delta-9-tetrahydrocannabinol (THC), the major active component of marijuana, has a beneficial effect on the cardiovascular system during stress conditions, but the defence mechanism is still unclear. The present study was designed to investigate the central (CB1) and the peripheral (CB2) cannabinoid receptor expression in neonatal cardiomyoctes and possible function in the cardioprotection of THC from hypoxia. Pre-treatment of cardiomyocytes that were grown in vitro with 0.1 – 10 μM THC for 24 h prevented hypoxia-induced lactate dehydrogenase (LDH) leakage and preserved the morphological distribution of α-sarcomeric actin. The antagonist for the CB2 (10 μM), but not CB1 receptor antagonist (10 μM) abolished the protective effect of THC. In agreement with these results using RT-PCR, it was shown that neonatal cardiac cells express CB2, but not CB1 receptors. Involvement of NO in the signal transduction pathway activated by THC through CB2 was examined. It was found that THC induces nitric oxide (NO) production by induction of NO synthase (iNOS) via CB2 receptors. L-NAME (NOS inhibitor, 100 μM) prevented the cardioprotection provided by THC. Taken together, our findings suggest that THC protects cardiac cells against hypoxia via CB2 receptor activation by induction of NO production. An NO mechanism occurs also in the classical pre-conditioning process; therefore, THC probably pre-trains the cardiomyocytes to hypoxic conditions.
Key Wordshypoxia nitric oxide pre-conditioning receptors signal transduction
Unable to display preview. Download preview PDF.
- 2.Nahas G: Marihuana in Science and Medicine. Raven, New York, 1984Google Scholar
- 3.Ross SA, Elsohly MA: Constituents of Cannabis sativa L. XXVIII. A review of the natural constituents:1980–1994. Zagazig J Pharmacol Sci 4: 1–10, 1995Google Scholar
- 5.McLendon DM, Harris RT, Maule WF: Suppression of the cardiac-conditioned response by delta-9-tetrahydrocannabinol: A comparison with other drugs. Psychopharmacology (Berl) 50: 159–163, 1976Google Scholar
- 12.Krylatov AV, Bernatskaia NA, Maslov LN, Pertwee RG, Mechoulam R, Stefano GB, Sharaevskii MA, Sal'nikova OM: Increase of the heart arrhythmogenic resistance and decrease of the myocardial necrosis zone during activation of cannabinoid receptors. Ross Fiziol Zh Im I M Sechenova 88: 560–567, 2002PubMedGoogle Scholar
- 18.Shainberg A, Safran N, Balas N, Zinman T, Isaac A, Schwab K, Akabayov B, Shneyvays V: The role of A1/A3 adenosine receptor activation in reduction of cardiomyocyte injury caused by hypoxic stress and in induction of apoptosis in rat cardiomyocyte cultures. Adv Exp Med Biol 486: 201–205, 2000PubMedGoogle Scholar
- 22.Jarai Z, Wagner JA, Varga K, Lake KD, Compton DR, Martin BR, Zimmer AM, Bonner TI, Buckley NE, Mezey E, Razdan RK, Zimmer A, Kunos G: Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc Natl Acad Sci USA 96: 14136–14141, 1999CrossRefPubMedGoogle Scholar
- 24.Randall RC: Cancer Treatment and Marijuana Therapy. Galen, 1990Google Scholar
- 25.Randall RC: Marijuana and AIDS: Pot, Politics and PWAs in America. Galen, 1991Google Scholar
- 28.Downer E, Boland B, Fogarty M, Campbell V: Delta 9-tetrahydrocannabinol induces the apoptotic pathway in cultured cortical neurones via activation of the CB1 receptor. Neuroreport 12: 3973–3978, 2001Google Scholar
- 39.Shiono N, Rao V, Weisel RD, Kawasaki M, Li RK, Mickle DA, Fedak PW, Tumiati LC, Ko L, Verma S: L-arginine protects human heart cells from low-volume anoxia and reoxygenation. Am J Physiol 282: H805–H815, 2002Google Scholar